Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs78028836 | chr12:12485448 | G/A | 2.1E-8 | 171 | 25.17 | 28.47 | 7.2 | KM Plot |
PCPG | rs78028911 | chr7:158852932 | A/AC | 0.000211 | 173 | 25.4 | 23.35 | 41.87 | KM Plot |
PCPG | rs7802896 | chr7:158682566 | G/A | 0 | 177 | 25.53 | 20.37 | 3.17 | KM Plot |
PCPG | rs7803188 | chr7:158682802 | G/C | 0 | 176 | 25.53 | 21.9 | 3.17 | KM Plot |
PCPG | rs78045362 | chr5:50319835 | A/G | 1.69E-5 | 170 | 24.62 | 32.92 | 13.5 | KM Plot |
PCPG | rs78067009 | chr12:124019231 | C/T | 0.000484 | 172 | 25.87 | 19.2 | 20.13 | KM Plot |
PCPG | rs7807070 | chr7:158683022 | G/A | 0 | 175 | 25.53 | 20.37 | 3.17 | KM Plot |
PCPG | rs78072538 | chr12:124074848 | A/T | 0.000427 | 174 | 25.87 | 19.2 | 20.13 | KM Plot |
PCPG | rs78075679 | chr5:171530844 | C/T | 0.000114 | 177 | 25.87 | 22.3 | 17.12 | KM Plot |
PCPG | rs78092914 | chr17:1410457 | G/C | 1.46E-5 | 174 | 25.05 | 25 | 25.17 | KM Plot |
PCPG | rs78109255 | chr16:8763608 | C/T | 0 | 178 | 25.47 | 23.53 | 3.17 | KM Plot |
PCPG | rs78121408 | chr12:56684798 | C/T | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs78124116 | chr15:39756236 | A/T | 0.00047 | 175 | 25 | 26.47 | 26.33 | KM Plot |
PCPG | rs78137576 | chr7:158681553 | C/T | 0 | 178 | 25.53 | 21.9 | 3.17 | KM Plot |
PCPG | rs78144687 | chr17:1441661 | T/C | 1.56E-5 | 173 | 25.4 | 26.73 | 13.18 | KM Plot |